[1] |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020; 396, 1204−22. doi: 10.1016/S0140-6736(20)30925-9 |
[2] |
Li L, Liu YN, Wu P, et al. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health, 2019; 4, e473−81. doi: 10.1016/S2468-2667(19)30163-X |
[3] |
Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U. S. adults. N Engl J Med, 2015; 373, 415−27. doi: 10.1056/NEJMoa1500245 |
[4] |
Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization. N Engl J Med, 2015; 373, 2382. |
[5] |
Shen Y, Feng ZM, Zhang DT, et al. Mitigated transmission and health impact of COVID-19 in Beijing, China during spring 2024: Comparison with the global trends. Sci Bull, 2024; 69, 3212−15. doi: 10.1016/j.scib.2024.07.047 |
[6] |
Shen Y, Liu YH, Krafft T, et al. Progress and challenges in infectious disease surveillance and early warning. Med Plus, 2025; 2, 100071. doi: 10.1016/j.medp.2025.100071 |
[7] |
Li ZJ, Zhang HY, Ren LL, et al. Etiological and epidemiological features of acute respiratory infections in China. Nat Commun, 2021; 12, 5026. doi: 10.1038/s41467-021-25120-6 |
[8] |
Liu YN, Zhang YF, Xu Q, et al. Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. Lancet Microbe, 2023; 4, e330−39. doi: 10.1016/S2666-5247(23)00031-9 |
[9] |
Gong C, Huang F, Suo LD, et al. Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023. Euro Surveill, 2024; 29, 2300704. |
[10] |
Bakaletz LO. Viral-bacterial co-infections in the respiratory tract. Curr Opin Microbiol, 2017; 35, 30−5. doi: 10.1016/j.mib.2016.11.003 |